tiprankstipranks
Swedish Orphan Biovitrum Ab (GB:0MTD)
:0MTD
UK Market

Swedish Orphan Biovitrum AB (0MTD) Income Statement

Compare
2 Followers

Swedish Orphan Biovitrum AB Income Statement

Last quarter (Q4 2022), Swedish Orphan Biovitrum AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Swedish Orphan Biovitrum AB's net income was $1.39B. See Swedish Orphan Biovitrum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 14.01B$ 12.04B$ 12.04B$ 10.91B$ 6.72B
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ 6.20B$ 5.72B$ 6.69B$ 6.08B$ 3.62B
Operating Income
$ 3.85B$ 3.79B$ 4.46B$ 4.50B$ 3.13B
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 2.64B$ 2.68B$ 3.25B$ 3.30B$ 2.42B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Swedish Orphan Biovitrum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis